TY - JOUR
T1 - Cardiomyopathy diagnosis model from endomyocardial biopsy specimens
T2 - Appropriate feature space and class boundary in small sample size data
AU - Mori, Masaya
AU - Omae, Yuto
AU - Koyama, Yutaka
AU - Hara, Kazuyuki
AU - Toyotani, Jun
AU - Okumura, Yasuo
AU - Hao, Hiroyuki
N1 - Publisher Copyright:
© 2025 the Author(s), licensee AIMS Press.
PY - 2025
Y1 - 2025
N2 - As the number of patients with heart failure increases, machine learning (ML) has garnered attention in cardiomyopathy diagnosis, driven by the shortage of pathologists. However, endomyocardial biopsy specimens are often limited in sample size and require techniques such as feature extraction and dimensionality reduction. This study investigated the effectiveness of texture features in the context of feature extraction for the pathological diagnosis of cardiomyopathy. Furthermore, model designs that contributed to improving generalization performance were examined by applying feature selection (FS) and dimensional compression (DC) to several ML models. The obtained results were verified by visualizing the inter-class distribution differences and conducting statistical hypothesis testing based on texture features. Additionally, they were evaluated using predictive performance across different model designs with varying combinations of FS and DC (applied or not) and decision boundaries. The obtained results confirmed that texture features may be effective for the pathological diagnosis of cardiomyopathy. Moreover, when the ratio of features to the sample size is high, a multi-step process involving FS and DC improved the generalization performance, with the linear kernel support vector machine achieving the best results. This process was demonstrated to be potentially effective for models with reduced complexity, regardless of whether the decision boundaries were linear, curved, perpendicular, or parallel to the axes. These findings are expected to facilitate the development of an effective cardiomyopathy diagnostic model for its rapid adoption in medical practice.
AB - As the number of patients with heart failure increases, machine learning (ML) has garnered attention in cardiomyopathy diagnosis, driven by the shortage of pathologists. However, endomyocardial biopsy specimens are often limited in sample size and require techniques such as feature extraction and dimensionality reduction. This study investigated the effectiveness of texture features in the context of feature extraction for the pathological diagnosis of cardiomyopathy. Furthermore, model designs that contributed to improving generalization performance were examined by applying feature selection (FS) and dimensional compression (DC) to several ML models. The obtained results were verified by visualizing the inter-class distribution differences and conducting statistical hypothesis testing based on texture features. Additionally, they were evaluated using predictive performance across different model designs with varying combinations of FS and DC (applied or not) and decision boundaries. The obtained results confirmed that texture features may be effective for the pathological diagnosis of cardiomyopathy. Moreover, when the ratio of features to the sample size is high, a multi-step process involving FS and DC improved the generalization performance, with the linear kernel support vector machine achieving the best results. This process was demonstrated to be potentially effective for models with reduced complexity, regardless of whether the decision boundaries were linear, curved, perpendicular, or parallel to the axes. These findings are expected to facilitate the development of an effective cardiomyopathy diagnostic model for its rapid adoption in medical practice.
KW - cardiomyopathy
KW - dimensionality reduction
KW - endomyocardial biopsy
KW - low sample size
KW - machine learning
KW - pathology image analysis
KW - texture analysis
UR - https://www.scopus.com/pages/publications/105009947876
U2 - 10.3934/bioeng.2025014
DO - 10.3934/bioeng.2025014
M3 - Article
AN - SCOPUS:105009947876
SN - 2375-1495
VL - 12
SP - 283
EP - 313
JO - AIMS Bioengineering
JF - AIMS Bioengineering
IS - 2
ER -